The management of leptospirosis

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 4, 2004, Pages 819-827

  Faucher, Jean François ^a   Hoen, Bruno ^a   Estavoyer, Jean Marie ^a  

^a HÔPITAL SAINT JACQUES   (France)

Author keywords

Antibiotics; Diagnosis; Leptospirosis; Management; Prophylaxis; Therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BACAMPICILLIN; CEFADROXIL; CEFALEXIN; CEFAMANDOLE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; LATAMOXEF; MACROLIDE; METRONIDAZOLE; MEZLOCILLIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; SULBACTAM; SULFAMIDE DERIVATIVE; TELITHROMYCIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONJUNCTIVA DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG CHOICE; DRUG FATALITY; DRUG HALF LIFE; FEVER; GASTROINTESTINAL SYMPTOM; HERXHEIMER REACTION; HUMAN; IN VITRO STUDY; JAUNDICE; KIDNEY FAILURE; LEPTOSPIROSIS; LEUKOCYTOSIS; LIVER DYSFUNCTION; LUNG DISEASE; POLYMERASE CHAIN REACTION; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UVEITIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CLINICAL TRIALS; DOXYCYCLINE; HUMANS; LEPTOSPIROSIS; PENICILLINS; POLYMERASE CHAIN REACTION; UVEITIS;

EID: 1842843707     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.4.819     Document Type: Review

References (62)

1. TREVEJO RT, RIGAU-PEREZ JG, ASHFORD DA et al.: Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J. Infect. Dis. (1998) 178:1457-1463.
2. KO AI, GALVAO REIS M, RIBEIRO DOURADO CM, JOHNSON WD Jr, RILEY LW: Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet (1999) 354:820-825.
3. ESTAVOYER JM, TRAN TA, HOEN B: Leptospiroses. Rev. Prat. (2001) 51:2086-2090.
4. LEVETT PN: Leptospirosis. Clin. Microbiol. Rev. (2001) 14:296-326.
5. KATZ AR, ANSDELL VE, EFFLER PV, MIDDLETON CR, SASAKI DM: Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974 - 1998. Clin. Infect. Dis. (2001) 33:1834-1841.
6. SASAKI DM, PANG L, MINETTE HP, et al.: Active surveillance and risk factors for leptospirosis in Hawaii. Am. J. Trop. Med. Hyg. (1993) 48:35-43.
7. BAL AM, KAKRANI AL, BHARADWAJ RS, KAGAL AS, JOSHI SA, ARJUNWADKAR VP: Evaluation of clinical criteria for the diagnosis of leptospirosis. J. Assoc. Physicians India (2002) 50:394-396.
8. MERIEN F, BARANTON G, PEROLAT P: Comparison of polymerase chain reaction with microagglutination test and culture for diagnosis of leptospirosis. J. Infect. Dis. (1995) 172:281-285.
9. YERSIN C, BOVET P, SMITS HL, PEROLAT P: Field evaluation of a one-step dipstick assay for the diagnosis of human leptospirosis in the Seychelles. Trop. Med. Int. Health (1999) 4:38-45.
10. SMITS HL, ANANYINA YV, CHERESHSKY A et al.: International multicenter evaluation of the clinical utility of a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human serum specimens. J. Clin. Microbiol. (1999) 37:2904-2909.
11. CUMBERLAND P, EVERARD CO, WHEELER JG, LEVETT PN: Persistence of anti-leptospiral IgM, IgG and agglutinating antibodies in patients presenting with acute febrile illness in Barbados 1979 - 1989. Eur. J. Epidemiol. (2001) 17:601-608.
12. MERIEN F, AMOURIAUX P, PEROLAT P, BARANTON G, SAINT GIRONS I: Polymerase chain reaction for detection of Leptospira spp. in clinical samples. J. Clin. Microbiol. (1992) 30:2219-2224.
13. TRUCCOLO J, SERAIS O, MERIEN F, PEROLAT P: Following the course of human leptospirosis: Evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Micrabiol. Lett. (2001) 204:317-321.
14. CUMBERLAND P, EVERARD CO, LEVETT PN: Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis. Am. J. Trop. Med. Hyg. (1999) 61:731-734.
15. GUSSENHOVEN GC, VAN DER HOORN MA, GORIS MG et al.: LEPTO dipstick, a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human sera. J. Clin. Microbiol. (1997) 35:92-97.
16. SMITS HL, EAPEN CK, SUGATHAN S et al.: Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin. Diagn Lab. Immunol. (2001) 8:166-169.
17. SILVA MV, CAMARGO ED, BATISTA L et al.: Behaviour of specific IgM, IgG and IgA class antibodies in human leptospirosis during the acute phase of the disease and during convalescence. J. Trop. Med. Hyg. (1995) 98:268-72.
18. PANAPHUT T, DOMRONGKITCHAIPORN S, VIBHAGOOL A, THINKAMROP B, SUSAENGRAT W: Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin. Infect. Dis. (2003) 36:1507-1513.
19. VIJAYACHARI P, SUGUNAN AP, SEHGAL SC: Evaluation of Lepto Dri Dot as a rapid test for the diagnosis of leptospirosis. Epidemiol. Infect. (2002) 129:617-621.
20. FARR RW: Leptospirosis. Clin. Infect. Dis. (1995) 21:1-6.
21. VINETZ JM: A mountain ouD of a molehill: do we treat acute leptospirosis, and if so, with what? Clin. Infect. Dis. (2003) 36:1514-1515.
22. OIE S, HIRONAGA K, KOSHIRO A, KONISHI H, YOSHII Z: In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents. Antimicrob. Agents Chemother. (1983) 24:905-908.
23. SHALIT I, BARNEA A, SHAHAR A: Efficacy of ciprofloxacin against Leptospira interrogans serogroup icterohaemorrhagiae. Antimicrob. Agents Chemother. (1989) 33:788-789.
24. HOSPENTHAL DR, MURRAY CK: In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrob. Agents Chemother. (2003) 47:2646-2648.
25. KOBAYASHI Y: Clinical observation and treatment of leptospirosis. J. Infect. Chemother. (2001) 7:59-68.
26. PRESCOTT J: Treatment of leptospirosis. Cornell Vet. (1991) 81:7-12.
27. ALEXANDER AD, RULE PL: Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis. Antimicrob. Agents Chemother. (1986) 30:835-839.
28. TRUCCOLO J, CHARAVAY F, MERIEN F, PEROLAT P: Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob. Agents Chemother. (2002) 46:848-853.
29. MCCLAIN JB, BALLOU WR, HARRISON SM, STEINWEG DL: Doxycycline therapy for leptospirosis. Ann. Intern. Med. (1984) 100:696-698.
30. WATT G, PADRE LP, TUAZON ML et al.: Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet (1988) 1:433-435.
31. EDWARDS CN, NICHOLSON GD, HASSELL TA, EVERARD CO, CALLENDER J: Penicillin therapy in icteric leptospirosis. Am. J. Trop. Med. Hyg. (1988) 39:388-390.
32. COSTA E, LOPES AA, SACRAMENTO E et al.: Penicillin at the late stage of leptospirosis: A randomized controlled trial. Rev. Inst. Med. Trop. Sao Paulo (2003) 45:141-145.
33. GUIDUGLI F, CASTRO AA, ATALLAH AN: Antibiotics for leptospirosis (Cochrane Review) In: The Cochrane Library, Issue 2 (2003).
34. MAROTTO PC, MAROTTO MS, SANTOS DL, SOUZA TN, SEGURO AC: Outcome of leptospirosis in children. Am. J. Trop. Med. Hyg. (1997) 56:307-310.
35. ZAKI SR, SPIEGEL RA: Leptospirosis. In: Pathology of Emerging Infection (Vol. 2). Nelson AM, Horsburgh Jr CR (Eds), American Society for Microbiology, Washington D.C., USA (1998): 73-92.
36. CHU KM, RATHINAM R, NAMPERUMALSAMY P, DEAN D: Identification of Leptospira species in the pathogenesis of uveitis and determination of clinical ocular characteristics in south India. J. Infect. Dis. (1998) 177:1314-1321.
37. MANCEL E, MERIEN F, PESENTI L, SALINO D, ANGIBAUD G, PEROLAT P: Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust. NZ J. Ophthalmol. (1999) 27:380-386.
38. ZAKI SR, SHIEH WJ: Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The epidemic Working Group at Ministry of Health in Nicaragua. Lancet (1996) 347:535-536.
39. COURTIN JP, DI FRANCIA M, DU COUEDIC I et al.: Respiratory manifestations of leptospirosis. A retrospective study of 91 cases (1978 - 1994). Rev. Pneumol. Clin. (1998) 54:382-392.
40. MAROTTO PC, NASCIMENTO CM, ELUF-NETO J et al.: Acute lung injury in leptospirosis: Clinical and laboratory features, outcome, and factors associated with mortality. Clin. Infect. Dis. (1999) 29:1561-1563.
41. AMATO MB, BARBAS CS, MEDEIROS DM et al.: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N. Engl. J. Med. (1998) 338:347-354.
42. EMMANOUILIDES CE, KOHN OF, GARIBALDI R: Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome. Clin. Infect. Dis. (1994) 18:1004-1006.
43. ESTAVOYER JM, RACADOT E, COUETDIC G, LEROY J, GROSPERRIN L: Tumor necrosis factor in patients with leptospirosis. Rev. Infect. Dis. (1991) 13:1245-1246.
44. TAJIKI H, SALOMAO R: Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin. Infect. Dis. (1996) 23:1177-1178.
45. YUKAWA M, KAMATA H, OHBA S, KADOI K, MOCHIZUKI K: Effect of immune serum, an antibiotic, and a corticosteroid used alone or in combination on experimental leptospirosis in Mongolian gerbils (Meriones unguiculatus). J. Basic Microbiol. (1994) 34:49-55.
46. BOURDAIS A, LONJON B, VERGEZ-PASCAL R, FOURNIER A, AH LO W: Respiratory complications of leptospirosis. Apropos of 6 cases, 3 of which show hemodynamic studies. Med. Trop. (Mars) (1988) 48:149-160.
47. TRIVEDI SV, CHAVDA RK, WADIA PZ et al.: The role of glucocorticoid pulse therapy in pulmonary involvement in leptospirosis. J. Assoc. Physicians India (2001) 49:901-903.
48. BORER A, METZ I, GILAD J et al.: Massive pulmonary haemorrhage caused by leptospirosis successfully treated with nitric oxide inhalation and haemofiltration. J. Infect. (1999) 38:42-45.
49. SEGURO AC, LOMAR AV, ROCHA AS: Acute renal failure of leptospirosis: Nonoliguric and hypokaliemic forms. Nephron (1990) 55:146-151.
50. PANAPHUT T, DOMRONGKITCHAIPORN S, THINKAMROP B: Prognostic factors of death in leptospirosis: A prospective cohort study in Khon Kaen, Thailand. Int. J. Infect. Dis. (2002) 6:52-59.
51. SITPRIJA V, LOSUWANRAK K, KANJANABUCH T: Leptospiral nephropathy. Semin. Nephrol. (2003) 23:42-48.
52. TSE KC, YIP PS, HUI KM et al.: Potential benefit of plasma exchange in treatment of severe icteric leptospirosis complicated by acute renal failure. Clin. Diagn Lab. Immunol. (2002) 9:482-484.
53. EDWARDS CN, NICHOLSON GD, EVERARD CO: Thrombocytopenia in leptospirosis. Am. J. Trop. Med. Hyg. (1982) 31:827-829.
54. ISOGAI E, KITAGAWA H, ISOGAI H et al.: Effects of leptospiral lipopolysaccharide on rabbit platelets. Zentralbl. Bakteriol. (1989) 271:186-196.
55. DUVAL G, VAN DER LINDEN T, JACOB F et al.: Human polyvalent immunoglobulins: What is their value in thrombopenia in the course of leptospirosis? Presse Med. (1993) 22:1012.
56. DAVENPORT A, RUGMAN FP, DESMOND MJ, GANTA R: Is thrombocytopenia seen in patients with leptospirosis immunologically mediated? J. Clin. Pathol. (1989) 42:439-440.
57. WATT G, WARRELL DA: Leptospirosis and the Jarisch-Herxheimer reaction. Clin. Infect. Dis. (1995) 20:1437-1438.
58. FEKADE D, KNOX K, HUSSEIN K et al.: Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N. Engl. J. Med. (1996) 335:311-315.
59. FRIEDLAND JS, WARRELL DA: The Jarisch-Herxheimer reaction in leptospirosis: Possible pathogenesis and review. Rev. Infect. Dis. (1991) 13:207-210.
60. TAKAFUJI ET, KIRKPATRICK JW, MILLER RN et al.: An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N. Engl. J. Med. (1984) 310:497-500.
61. SEHGAL SC, SUGUNAN AP, MURHEKAR MV, SHARMA S, VIJAYACHARI P: Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int. J. Antimicrob. Agents. (2000) 13:249-255.
62. GONSALEZ CR, CASSEB J, MONTEIRO FG et al.: Use of doxycycline for leptospirosis after high-risk exposure in Sao Paulo, Brazil. Rev. Inst. Med. Trop. Sao Paulo (1998) 40:59-61.